176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
21.13%
Net income growth under 50% of MRVL's 45.10%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
5.94%
Some D&A expansion while MRVL is negative at -6.28%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-1921.79%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
1.71%
SBC growth while MRVL is negative at -12.11%. John Neff would see competitor possibly controlling share issuance more tightly.
148.52%
Less working capital growth vs. MRVL's 350.19%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-40.00%
AR is negative yoy while MRVL is 157.74%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-14.71%
Both reduce yoy inventory, with MRVL at -50.76%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-107.83%
Negative yoy AP while MRVL is 5.36%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
1868.39%
Some yoy usage while MRVL is negative at -13.11%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
1338.38%
Lower 'other non-cash' growth vs. MRVL's 3809.55%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
33.45%
Some CFO growth while MRVL is negative at -40.63%. John Neff would note a short-term liquidity lead over the competitor.
-45.28%
Both yoy lines negative, with MRVL at -12.75%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-25.46%
Negative yoy purchasing while MRVL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
133.18%
Liquidation growth of 133.18% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-4576.99%
Both yoy lines negative, with MRVL at -9800.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
6.81%
We have mild expansions while MRVL is negative at -33.73%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-191.09%
Both yoy lines negative, with MRVL at -50.00%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.